Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haochen Yang

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cancer Cell|May 27, 2023
Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunityChengsong Yan, Lin Zheng, Shutan Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 24, 2025
Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical StudiesYan Sun, Haochen Yang, Qing Xu, et al.
Cell Discovery|October 21, 2022
Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profilingJingwen Ai, Jingxin Guo, Haocheng Zhang, et al.
EMBO Molecular Medicine|January 4, 2024
Shaping immune landscape of colorectal cancer by cholesterol metabolitesYibing Bai, Tongzhou Li, Qinshu Wang, et al.
Cell|March 18, 2025
Ligand-induced ubiquitination unleashes LAG3 immune checkpoint function by hindering membrane sequestration of signaling motifsYong Jiang, Anran Dai, Yuwei Huang, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cancer Cell|May 27, 2023
Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunityChengsong Yan, Lin Zheng, Shutan Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 24, 2025
Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical StudiesYan Sun, Haochen Yang, Qing Xu, et al.
Cell Discovery|October 21, 2022
Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profilingJingwen Ai, Jingxin Guo, Haocheng Zhang, et al.
EMBO Molecular Medicine|January 4, 2024
Shaping immune landscape of colorectal cancer by cholesterol metabolitesYibing Bai, Tongzhou Li, Qinshu Wang, et al.
Cell|March 18, 2025
Ligand-induced ubiquitination unleashes LAG3 immune checkpoint function by hindering membrane sequestration of signaling motifsYong Jiang, Anran Dai, Yuwei Huang, et al.
Pageof 5